Bayer wins crucial US Supreme Court ruling over Roundup weedkiller

The US Supreme Court handed Bayer a major victory on June 25, 2026, ruling 7-2 in Monsanto v. Durnell that federal pesticide law preempts state failure-to-warn claims over Roundup labels that the Environmental Protection Agency has not required to carry a cancer warning.

The ruling is expected to affect thousands of pending lawsuits and remove one of the biggest legal and financial pressures Bayer has faced since it bought Monsanto in 2018.

John Durnell, the plaintiff in the case, had won a $1.25 million jury award before the Supreme Court overturned the verdict. The dispute focused on whether state law could require a warning beyond the label position allowed under federal pesticide rules.

The ruling

According to reporting on the decision, Justice Brett Kavanaugh wrote for the court. Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch.

The court’s holding turns on federal preemption. In practical terms, the majority said state-law warning claims cannot stand where the EPA has not required the cancer warning plaintiffs say should have been on the label.

That matters because much of the Roundup litigation has been built around the argument that Monsanto, now owned by Bayer, should have warned users that glyphosate-based weedkiller might cause cancer.

The decision does not end every lawsuit tied to Roundup, but it sharply undercuts the warning-based theory that has driven a large share of the cases.

Why Bayer views it as a breakthrough

Bayer has spent years trying to contain the Roundup dispute, which has been one of its largest legal and financial burdens since the Monsanto acquisition.

AP reported the company has faced about 200,000 claims and had already set aside $16 billion for settlements. Reporting also says Bayer has proposed a separate $7.25 billion settlement that continues apart from the Supreme Court ruling.

After the decision, Bayer said it should help contain Roundup litigation and lead to dismissal of current warning-based claims, while also barring future failure-to-warn suits of the same kind.

The company also framed the ruling as a win for science, farmers and industries that depend on regulatory clarity for innovation.

How the Roundup fight got here

Roundup litigation has stretched on for years and has become one of the best-known product-liability fights in the US.

The herbicide issue intensified after Bayer acquired Monsanto in 2018 and inherited the Roundup-related lawsuits already building around the product.

Plaintiffs have argued for years that Roundup should have carried a cancer warning. Bayer has countered that federal pesticide regulators, not state tort law, should control the label.

The Durnell case brought that broader conflict to the Supreme Court and gave the justices a chance to decide how far EPA-based labeling decisions preempt state claims.

What the decision changes

The most immediate consequence is likely to be a push by Bayer to have pending warning-based cases dismissed or narrowed.

Because the ruling goes to the legal theory behind many of the claims, it could quickly reshape how lower courts handle the Roundup docket.

The ruling may also reduce pressure on Bayer in settlement talks by weakening one of the plaintiffs’ strongest leverage points.

At the same time, the decision does not automatically dispose of every Roundup-related claim. Other theories of liability may still be litigated, and Bayer’s broader settlement work remains in play.

Broader implications

The case may matter beyond Roundup. It strengthens the argument that EPA-approved pesticide labeling can preempt state-law warning claims, a point likely to be watched closely in other pesticide disputes.

That makes the ruling a potential precedent for how courts treat conflicts between federal regulator-approved labels and state tort claims in future chemical cases.

Environmental and public-health advocates have argued that EPA label approval does not prove a product is safe and should not erase state-law remedies. That criticism is likely to continue as plaintiffs test the limits of the decision.

What happens next

The next questions are practical rather than theoretical.

Lower courts will have to decide how quickly to apply the ruling to pending Roundup cases and which claims, if any, can still proceed under different legal theories.

It remains unclear how the decision will affect Bayer’s separate settlement efforts or whether plaintiffs will try to shift more aggressively toward non-warning claims.

Regulatory and political reactions are also worth watching, including whether the EPA or other federal agencies comment publicly on the decision’s scope.

For Bayer, the ruling marks a substantial reduction in litigation risk. For Roundup plaintiffs, it is a major setback that could narrow the path for future claims.

For the broader pesticide industry, it is a signal that federal labeling decisions may carry more weight in court than many plaintiffs had hoped.

,